Artificial Intelligence
Luminate and Silicon Catalyst Form Partnership to Speed Development of Emerging Technologies
ROCHESTER, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) — Luminate NY—the world’s largest accelerator for startups developing optics, photonics, and imaging (OPI) enabled technologies—announced today that it has formed a strategic partnership with Silicon Catalyst, the world’s only incubator focused on accelerating semiconductor solutions. Under the joint partnership, the two organizations will work closely together to recruit the most innovative early-stage startups into their accelerator programs to allow for concurrent participation. This will expand the support ecosystem for founders working on industry solutions that are enabled by OPI and semiconductor chip design to ultimately reduce the cost and complexity of development.
“Critical technologies such as silicon photonics, lasers, and electronic packaging rely on the integration of semiconductor technology and photonics. These complex integrations are the building blocks of emerging applications like autonomous sensing, augmented reality, artificial intelligence, and quantum applications,” said Sujatha Ramanujan, Managing Director, Luminate NY. “This partnership will help to close the development and manufacturing gaps that often exist when working across multiple technical disciplines to bring novel technologies to market.”
The partnership will also improve access to funding opportunities for early-stage companies. Startups developing OPI-based products receive $100,000 upon admission to Luminate and have the chance to compete for up to $2 million on follow-on funding to support their growth. In addition, over the past 8 years, Silicon Catalyst has enabled access to over $400M in funding to its portfolio companies, as well as over $200 million derived from both in-kind services and grants.
Owl Autonomous Imaging, an early-stage company that earned a spot in the Silicon Catalyst’s 24-month accelerator in 2018, experienced this problem firsthand when it needed to integrate optics and imaging with machine learning and silicon chip design in order to deliver the first monocular 3D Thermal Ranging solution to the autonomous vehicle industry. After it graduated Silicon Catalyst’s program, it was accepted into Luminate’s fourth cohort in 2021. During this time period, the company had to execute on a very aggressive schedule for chip-level development, while at the same time, build a complete imaging automotive-grade system solution.
“Working together with both Silicon Catalyst and Luminate, we were able to leverage their strategic and in-kind partners, financiers, advisors, and mentors to build a solid company foundation and, ultimately, introduce a world-first solution,” said Gene Petilli, Co-founder and Chief Technology Officer, Owl Autonomous Imaging.
Owl’s patented 3D Thermal Ranger™ provides HD imaging and precision ranging, which represents a 150x improvement in resolution and cloud density of LiDAR. It operates both day and night, in all weather, to definitively classify pedestrians, cyclists, animals, and vehicles, all the while calculating position, direction, and speed to unlock safe autonomous and semi-autonomous operation.
“Owl’s success helped Silicon Catalyst and Luminate validate the impact that a strategic partnership could have on the development trajectory of groundbreaking technologies,” said Silicon Catalyst partner Lance Bell. “By formalizing this relationship and working together, we will be able to more effectively screen and evaluate each startup’s potential, closely pair our cohort companies to mentors and resources to speed time to market, and de-risk investments.”
Benefits like these have helped Owl’s growth trajectory. In July, the company made public its plans to move to a larger headquarters and expand its operations, including adding up to 105 jobs.
In addition to providing the ability to participate in both programs concurrently, the partnership will increase startup access to connections, collaborations, and funding. Luminate and Silicon Catalyst will collaborate on startup recruitment and selection, with a focus on elevating women and minority owned companies to ensure equitable access to comprehensive support. The organizations will also leverage their investor networks and portfolios to improve funding opportunities.
Silicon Catalyst provides critical support to semiconductor hardware startups as they move from idea through prototype to initial product. Since its founding in 2015, it has reviewed over 700 early-stage companies and admitted 88 startups into its incubator. The companies get access to tools and services from a comprehensive network of In-Kind Partners (IKPs)—including design tools, simulation software, design services, foundry PDK access and MPW runs, test program development, and tester access—which dramatically reduces the cost of chip development. Additionally, the startups tap into the world-class Silicon Catalyst ecosystem of advisors, investors and academic research organizations. In 2021, Silicon Catalyst was named Semiconductor Review’s Top-10 Solutions Company award winner with its portfolio companies currently valued at over $1.5 billion.
Since its inception in 2018, Luminate has reviewed nearly 600 early-stage companies from around the world for entrance into its competitive, six-month accelerator program, and has accepted and invested $15 million in 53 startups. The companies in the portfolio now share a net worth of over $400 million, and many are establishing U.S. operations or some aspect of research and manufacturing in the Rochester and Finger Lakes New York region, which has long been viewed as the optics and imaging capital of the world.
Luminate is now recruiting for Cohort 6. Startups interested in applying are encouraged to register for an upcoming information session, or apply by Jan. 9, 2023.
The strategic partnership dovetails on recent news that highlights New York’s deepening commitment to both OPI and semiconductor capabilities, which includes funding for Luminate for four more years from Empire State Development’s Finger Lakes Forward Upstate Revitalization Initiative, and Micron’s plans to invest $100 billion transform Central NY into a global, leading-edge semiconductor manufacturing hub.
For more information on Luminate NY, visit: https://luminate.org/. More information on Silicon Catalyst is available at https://siliconcatalyst.com/ and https://www.siliconcatalystangels.com/.
Artificial Intelligence
Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms
MARKHAM, ON, April 25, 2024 /PRNewswire/ — Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.
SONIFI Health is a leading U.S. healthcare technology company based in Sioux Falls, South Dakota. The new partnership leverages and integrates Enghouse Video room systems technology to support SONIFI Health’s commitment to expanding telehealth applications and system optimizations in hospital settings.
Enghouse’s VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware solutions, has been fully integrated into SONIFI Health’s interactive TV systems. This integration provides up to 4K high-quality video conferencing, multi-party sessions and robust security features that ensure full compliance with healthcare regulations.
Enghouse Video offers an immersive telehealth platform to support collaborative interdisciplinary care, improved patient outcomes and cost savings. The platform is flexible and simple, delivering the reliability, interoperability, and scalability needed for today’s healthcare environment. A key strength of the partnership is its offering of back-end integrations like patient portals, medical devices, EMR, tele-sitting, remote patient observation and consultation.
“Hospitals can choose the telehealth partner that’s right for them, and we incorporate that solution with interactive TV,” said Brian Nido, SONIFI Health’s Vice President of Customer Success. “Using the hardware and systems they already have in patient rooms helps hospitals reduce costs and maximize the value of their existing investments, while benefiting both clinicians and patients.”
SONIFI Health and Enghouse Video continue to collaborate closely to further refine and enhance the telehealth solutions provided to healthcare facilities. This partnership reflects a shared commitment to leveraging technology to create smarter hospital rooms and improve patient care across the healthcare spectrum.
About Enghouse VideoEnghouse Video, part of the Enghouse Interactive division, is a subsidiary of Enghouse Systems Limited, a vertically focused software and services company traded on the Toronto Stock Exchange (TSX: ENGH). Through highly secure, scalable and flexible Cloud-based or On Prem services, we deliver one of the world’s highest quality and most innovative video platform to video-enable any application or idea. From advanced video conferencing and collaboration tools to state-of-art enterprise video management, Enghouse Video is a unique player in multiple markets, including telehealth. Learn more at www.enghousevideo.com, read our blog, or follow us on Twitter at @EnghouseVideo, on LinkedIn, and on Facebook.
About SONIFI HealthSONIFI Health provides market-leading interactive patient engagement technology proven to improve patient outcomes and staff productivity. The EHR-integrated platform is designed to enhance patient and family experiences while increasing staff satisfaction and organizations’ operational efficiencies. As part of SONIFI Solutions, Inc., the company annually supports more than 300 million end user experiences. Learn more at sonifihealth.com.
Enghouse Video Contact: Sylvain Awad, Director, Demand Generation, Enghouse Video, part of Enghouse Interactive Division, [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms-302126882.html
Artificial Intelligence
Global Insurance Provider Selects 3CLogic to Streamline AI and Contact Center Capabilities with ServiceNow
Multinational Insurance Broker to deploy 3CLogic’s solution with ServiceNow’s Financial Service Operations (FSO) platform to streamline customer experiences.
ROCKVILLE, Md., April 25, 2024 /PRNewswire/ — 3CLogic, the leading Conversational AI and Contact Center solution for ServiceNow®, today announced its selection by a global insurance provider to replace its existing contact center infrastructure as part of a larger CX transformation effort. The strategic decision is designed to complement the organization’s use of ServiviceNow’s Financial Services Operations (FSO) offering leveraged across a number of its existing product lines including Customer Warranty Claims, Roadside Assistance, and Home Warranties.
Serving millions of customers worldwide with innovative insurance and protective products, the organization required a solution that would enhance its recent investment in the ServiceNow platform as it works to transform its end-to-end customer service operations. The deployment will incorporate several of 3CLogic’s AI-powered capabilities purpose-built for ServiceNow, including Conversational AI, Speech Analytics, and AI Performance & Coaching, along with integrated call transcriptions, convenient 2-way SMS, and ServiceNow-centralized contact center reporting.
“We continue to see enterprises eager to complement their existing investment in digital platforms, such as ServiceNow, with contact center features purpose-built to extend the workflows and features they already have and use,” explains Matt Durkin, VP of Global Sales at 3CLogic. “It’s no secret that organizations are already juggling too many systems, often with overlapping capabilities, which impacts ROI and operational efficiency. We’re proud to offer an alternative approach that helps simplify the technology stack while optimizing the overall operational costs and outcomes.”
Recently named to Constellation Research’s 2024 Shortlist for Digital Customer Service and Support, 3CLogic has seen global adoption of its solution by leading enterprises in healthcare, manufacturing, travel, retail, higher education, finance, non-profits, and Managed Service Providers across five continents. As a ServiceNow-certified Technology and Build partner with offerings available for ServiceNow’s IT Service Management, Customer Workflows, HR Service Delivery, and Source-to-Pay solutions, the company will be unveiling its latest set of capabilities at ServiceNow’s annual Knowledge 2024 event this May in Las Vegas.
For more information, please contact [email protected].
About 3CLogic3CLogic transforms customer and employee experiences with its leading Cloud Contact Center and AI solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative features such as intelligent self-service, generative and Conversational AI, agent automation & coaching, and AI-powered sentiment analytics – all designed to lower operational costs, maximize ROI, and optimize each interaction across IT Service Desks, Customer Support, Sales or HR Services teams. For more information, please visit www.3clogic.com.
Logo – https://mma.prnewswire.com/media/2318845/3CLogic_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow-302127739.html
Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
NIJMEGEN, Netherlands, April 25, 2024 /PRNewswire/ — ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint’s commercial growth and success over the past 2 years.
The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint’s flagship Transpara software to support millions of scans a year.
“I am thrilled to lead ScreenPoint into its next phase of growth and innovation,” said Mr. Kroese. “I am deeply committed to building upon the strong foundation we have and continuing to work closely with our talented team to drive continued success. We are already expanding screening capacity and capability through proven reader support – we look forward to increasing our ability to support providers and women moving forward.”
Sir Michael Brady, Chairman of the Board at ScreenPoint Medical and a co-founder of the company, expressed enthusiasm about Pieter’s appointment, stating, “Pieter’s remarkable leadership qualities, coupled with his depth of knowledge of our product and industry, make him the perfect choice to lead ScreenPoint into the future. His strategic mindset and commitment to excellence align perfectly with our company mission of early breast cancer detection. Pieter has been an integral part of our growth to date and will provide seamless leadership through this transition into our next chapter for our customers, partners, and team.”
Author of “No Longer Radical” and over a hundred peer-reviewed publications on breast imaging, Dr. Rachel Brem is a Transpara user and ScreenPoint Board Member. Dr. Brem welcomed Mr. Kroese with the following: “Pieter has been an integral part of the ScreenPoint team for years. I am confident that his leadership will continue to deliver product excellence: earlier detection with outstanding reading workflow and improved patient outcomes. We continue to see these results from clinical sites all over the world, including many here in the United States. No other Breast AI solution has demonstrated the same results as Transpara, and I am confident that the team will continue to push on these frontiers under Pieter’s leadership.”
The entire team at ScreenPoint extends its gratitude to Mark Koeniguer and wishes him every success in the future, while warmly welcoming Pieter Kroese into his new role as CEO.
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers.
See all the proof at: https://screenpoint-medical.com/evidence.
Photo: https://mma.prnewswire.com/media/2397831/Pieter_Kroese_CEO_ScreenPoint_Medical.jpgLogo: https://mma.prnewswire.com/media/1582198/ScreenPoint_Medical_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/screenpoint-medical-leadership-transition-pieter-kroese-confirmed-as-ceo-302127719.html
-
Uncategorized6 days agoGenerative AI gold rush drives IT spending — with payoff in question
-
Uncategorized6 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized6 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized6 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence6 days agoFree Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized6 days ago
Can artificial intelligence reduce vehicle time to market?
-
Uncategorized6 days ago
The Ottawa Hospital doctors to try AI for patient notes
-
Artificial Intelligence5 days agoAurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
